ID: ALA3962679

Max Phase: Preclinical

Molecular Formula: C29H32N6O6S

Molecular Weight: 592.68

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)Nc1ccc(CC(=O)Nc2ccc(C[C@H](NC(=O)[C@@H]3CCCN3S(=O)(=O)c3ccccc3)C(=O)O)cc2)cc1

Standard InChI:  InChI=1S/C29H32N6O6S/c30-29(31)33-22-14-10-20(11-15-22)18-26(36)32-21-12-8-19(9-13-21)17-24(28(38)39)34-27(37)25-7-4-16-35(25)42(40,41)23-5-2-1-3-6-23/h1-3,5-6,8-15,24-25H,4,7,16-18H2,(H,32,36)(H,34,37)(H,38,39)(H4,30,31,33)/t24-,25-/m0/s1

Standard InChI Key:  CWHBGPSHRUIMTO-DQEYMECFSA-N

Associated Targets(Human)

Integrin alpha-V/beta-1 222 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 592.68Molecular Weight (Monoisotopic): 592.2104AlogP: 2.14#Rotatable Bonds: 11
Polar Surface Area: 194.78Molecular Species: ZWITTERIONHBA: 6HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.18CX Basic pKa: 10.31CX LogP: 0.64CX LogD: 0.64
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.14Np Likeness Score: -1.05

References

1. Reed NI, Tang YZ, McIntosh J, Wu Y, Molnar KS, Civitavecchia A, Sheppard D, DeGrado WF, Jo H..  (2016)  Exploring N-Arylsulfonyl-l-proline Scaffold as a Platform for Potent and Selective αvβ1 Integrin Inhibitors.,  (10): [PMID:27774126] [10.1021/acsmedchemlett.6b00196]

Source